Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis

Table 8 Comparison of ANA at different titers between typed drug-induced liver injury and primary biliary cirrhosis patients n (%)

	1:100	1:320	1:1000	1:3200	1:10000
Hepatocellular type DILI (n = 90)	34 (37.7)a	7 (7.77)a	1 (1.11)a	0a	0
Cholestatic type DILI (n = 20)	5 (25.0)	2 (10.0)a	0a	1 (5.00)	0
Mixed type DILI (n = 14)	4 (28.5)	1 (7.14)	1 (7.14)	0 (0.00)	0
PBC (n = 116)	20 (17.2)	27 (23.2)	30 (25.8)	19 (16.3)	2 (1.72)

^aP < 0.05 vs the PBC group. Since the number of cases with ANA at a titer of 1:10000 was 0 in the hepatocellular type DILI, cholestatic type DILI, and mixed type DILI groups, comparisons between them cannot be done. DILI: Drug-induced liver injury; PBC: Primary biliary cirrhosis.